Tumor cells circulating within a patient’s bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease. Now researchers have developed a new microfluidic chip that can quickly and efficiently segregate and capture live circulating tumor cells (CTCs) from a patient’s blood, with potential applications for cancer screenings and treatment assessments.